Mode of lymph node metastases and validity of elective mediastinal lymph node dissection in patients with cancer of the upper lobes of the lung

Japanese Journal of Lung Cancer

Volumn 45, Issue 6, 2005, Pages 711-716

  Sakurai, Hiroyuki ^a,b,c   Shindo, Shunya ^a   Matsumoto, Masahiko ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Yamanashi Prefectural Central Hospital   (Japan)

Author keywords

Elective mediastinal lymph node dissection; Skip metastasis; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; CONTROLLED STUDY; DISEASE COURSE; ELECTIVE SURGERY; FEMALE; HUMAN; LUNG CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL KILLING; CELL SURVIVAL; CLONOGENIC ASSAY; CYTOTOXICITY; FLOW CYTOMETRY; HEAT TOLERANCE; HUMAN CELL; HYPERTHERMIA; LOW ENERGY RADIATION; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; WESTERN BLOTTING;

BENZYLIDENE DERIVATIVE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 72; N FORMYL 3,4 METHYLENEDIOXYBENZYLIDENE GAMMA BUTYROLACTAM; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ADAPTATION, PHYSIOLOGICAL; ADENOCARCINOMA; BENZHYDRYL COMPOUNDS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; HUMANS; HYPOTHERMIA; LACTAMS; PYRROLIDINONES; RADIATION DOSAGE; RADIATION TOLERANCE; TEMPERATURE;

EID: 31644449294     PISSN: 03869628     EISSN: None     Source Type: Journal    
DOI: 10.2482/haigan.45.711     Document Type: Article

References (16)

1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615-622.
2. Lederle FA. Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg. 1996;62:1249-1250.
3. Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1-6.
4. Okada M, Tsubota N, Yoshimura M, et al. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949-953.
5. Asamura H, Nakayama H, Kondo H, et al. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102-1111.
6. Shimosato Y, Suzuki A, Hashimoto T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol. 1980;4:365-373.
7. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978;76:832-839.
8. Gaer JA, Goldstraw P. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus. Eur J Cardiothorac Surg. 1990;4:207-210.
9. Takizawa T, Terashima M, Koike T, et al. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:248-252.
10. Yoshino I, Yokoyama H, Yano T, et al. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. Ann Thorac Surg. 1996;62:1021-1025.
11. Riquet M, Assouad J, Bagan P, et al. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis. Ann Thorac Surg. 2005;79:225-233.
12. Bollen EC, van Duin CJ, Theunissen PH, et al. Mediastinal lymph node dissection in resected lung cancer morbidity and accuracy of staging. Ann Thorac Surg. 1993;55:961-966.
13. Watanabe S, Asamura H, Suzuki K, et al. The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg. 2005;4:106-109.
14. Asamura H, Nakayama H, Kondo H, et al. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125-1134.
15. Graham AN, Chan KJ, Pastorino U, et al. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117:246-251.
16. Misthos P, Sepsas E, Athanassiadi K, et al. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;25:502-508.